Abstract
Mechanical circulatory devices have become common to support a failing heart, often as a temporizing measure prior to cardiac transplantation, and occasionally as destination therapy (Slaughter MS, J Heart Lung Transplant 29:S1–39, 2010). It restores tissue circulation by optimizing blood supply thereby enabling organ function. However, these devices could be associated with several challenges and complications and with increasing number of devices being implanted both as a bridge to transplant and destination therapy, it is necessary for the critical care and emergency physicians unfamiliar with them to understand the physiology, clinical presentations, and management of complications.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Slaughter MS, et al. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant. 2010;29(4 Suppl):S1–39.
Kormos RL, Miller LW. Mechanical circulatory support: a companion to Braunwald's heart disease: expert consult. Philadelphia, PA: Elsevier; 2011.
Joyce D, Joyce L, Locke M. Mechanical circulatory support: principles and applications 2011. New York: McGraw-Hill Professional.
Agarwal S, High KM. Newer-generation ventricular assist devices. Best Pract Res Clin Anaesthesiol. 2012;26(2):117–30.
Rogers JG, et al. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol. 2010;55(17):1826–34.
Pratt AK, Shah NS, Boyce SW. Left ventricular assist device management in the ICU. Crit Care Med. 2014;42(1):158–68.
Miller LW, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357(9):885–96.
Moazami N, et al. Axial and centrifugal continuous-flow rotary pumps: a translation from pump mechanics to clinical practice. J Heart Lung Transplant. 2013;32(1):1–11.
Nienaber J, Wilhelm MP, Sohail MR. Current concepts in the diagnosis and management of left ventricular assist device infections. Expert Rev Anti-Infect Ther. 2013;11(2):201–10.
Slaughter MS. Long-term continuous flow left ventricular assist device support and end-organ function: prospects for destination therapy. J Card Surg. 2010;25(4):490–4.
Uriel N, et al. Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices: the Columbia ramp study. J Am Coll Cardiol. 2012;60(18):1764–75.
O'Shea G. Ventricular assist devices: what intensive care unit nurses need to know about postoperative management. AACN Adv Crit Care. 2012;23(1):69–83; quiz 84–5
Feldman D, et al. The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant. 2013;32(2):157–87.
Kapur NK, Jumean MF Management of continuous flow left ventricular assist device patients in the Cardiac Catheterization Laboratory. www.cathlabdigest.com 2014. 22.
Morgan JA, et al. Impact of continuous-flow left ventricular assist device support on right ventricular function. J Heart Lung Transplant. 2013;32(4):398–403.
Imamura T, et al. Bosentan improved persistent pulmonary hypertension in a case after implantation of a left ventricular assist device. J Artif Organs. 2013;16(1):101–4.
Goldstein JA, Kern MJ. Percutaneous mechanical support for the failing right heart. Cardiol Clin. 2012;30(2):303–10.
Hottigoudar RU, et al. Catheter ablation of atrial flutter in patients with left ventricular assist device improves symptoms of right heart failure. Congest Heart Fail. 2013;19(4):165–71.
Nakahara S, et al. Ventricular arrhythmias after left ventricular assist device. Circ Arrhythm Electrophysiol. 2013;6(3):648–54.
Rajagopal K, et al. Natural history and clinical effect of aortic valve regurgitation after left ventricular assist device implantation. J Thorac Cardiovasc Surg. 2013;145(5):1373–9.
Patil NP, et al. De novo aortic regurgitation after continuous-flow left ventricular assist device implantation. Ann Thorac Surg. 2014;98(3):850–7.
John R, et al. Aortic valve pathophysiology during left ventricular assist device support. J Heart Lung Transplant. 2010;29(12):1321–9.
Allen SJ, Sidebotham D. Postoperative care and complications after ventricular assist device implantation. Best Pract Res Clin Anaesthesiol. 2012;26(2):231–46.
Morgan JA, et al. Management of aortic valve insufficiency in patients supported by long-term continuous flow left ventricular assist devices. Ann Thorac Surg. 2012;94(5):1710–2.
Mehra MR, Stewart GC, Uber PA. The vexing problem of thrombosis in long-term mechanical circulatory support. J Heart Lung Transplant. 2014;33(1):1–11.
Adatya S, et al. Loading conditions influence reliability of the echocardiographic ramp test in continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2013;32(11):1142–4.
Kapur NK, et al. Left ventricular assist device thrombosis presenting as an acute coronary syndrome. J Thorac Cardiovasc Surg. 2014;147(6):e72–3.
Velagic V, et al. Management of heparin-induced thrombocytopenia with fondaparinux in a patient with left ventricular assist device. Int J Organ Transplant Med. 2014;5(2):83–6.
Schroder JN, et al. Heparin-induced thrombocytopenia in left ventricular assist device bridge-to-transplant patients. Ann Thorac Surg. 2007;84(3):841–5; discussion 845–6.
Morgan JA, et al. Gastrointestinal bleeding with the HeartMate II left ventricular assist device. J Heart Lung Transplant. 2012;31(7):715–8.
Meyer AL, et al. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device. Circ Heart Fail. 2010;3(6):675–81.
Coutance G, et al. Octreotide for recurrent intestinal bleeding due to ventricular assist device. Asian Cardiovasc Thorac Ann. 2014;22(3):350–2.
Rennyson SL, et al. Octreotide for left ventricular assist device-related gastrointestinal hemorrhage: can we stop the bleeding? ASAIO J. 2013;59(4):450–1.
Patel AM, et al. Renal failure in patients with left ventricular assist devices. Clin J Am Soc Nephrol. 2013;8(3):484–96.
Wilson TJ, et al. Management of intracranial hemorrhage in patients with left ventricular assist devices. J Neurosurg. 2013;118(5):1063–8.
Morgan JA, et al. Stroke while on long-term left ventricular assist device support: incidence, outcome, and predictors. ASAIO J. 2014;60(3):284–9.
Kato TS, et al. Pre-operative and post-operative risk factors associated with neurologic complications in patients with advanced heart failure supported by a left ventricular assist device. J Heart Lung Transplant. 2012;31(1):1–8.
Kato TS, et al. Asymmetric pattern of cerebrovascular lesions in patients after left ventricular assist device implantation. Stroke. 2012;43(3):872–4.
Gordon RJ, et al. Prospective, multicenter study of ventricular assist device infections. Circulation. 2013;127(6):691–702.
Nienaber JJ, et al. Clinical manifestations and management of left ventricular assist device-associated infections. Clin Infect Dis. 2013;57(10):1438–48.
LaRue S, et al. Left ventricular assist device in pregnancy. Obstet Gynecol. 2011;118(2 Pt 2):426–8.
Sarsam SH, et al. Trauma in patients with continuous-flow left ventricular assist devices. Am J Cardiol. 2013;112(9):1520–2.
Reade MC. Temporary epicardial pacing after cardiac surgery: a practical review: part 1: general considerations in the management of epicardial pacing. Anaesthesia. 2007;62(3):264–71.
Rozner MA, Trankina M. Cardiac pacing and defibrillation. In: Kaplan JA, Reich DL, Lake CL, Konstadt SN, editors. Kaplan’s cardiac anesthesia. Philadelphia: W. B. Saunders; 2006. p. 827–43.
Atlee JL, Bernstein AD. Cardiac rhythm management devices (part II): perioperative management. Anesthesiology. 2001;95(6):1492–506.
Scales G Medtronic model 5388 dual chamber temporary pacemaker technical manual. 2006.
Timothy PR, Rodeman BJ. Temporary pacemakers in critically ill patients: assessment and management strategies. AACN Clin Issues. 2004;15(3):305–25.
Bojar RM, editor. Manual of perioperative care in adult cardiac surgery. 4th ed. Malden: Blackwell Publishing; 2004.
Spotnitz HM. Optimizing temporary perioperative cardiac pacing. J Thorac Cardiovasc Surg. 2005;129(1):5–8.
Elmi F, Tullo NG, Khalighi K. Natural history and predictors of temporary epicardial pacemaker wire function in patients after open heart surgery. Cardiology. 2002;98(4):175–80.
Daoud EG, et al. Randomized, double-blind trial of simultaneous right and left atrial epicardial pacing for prevention of post-open heart surgery atrial fibrillation. Circulation. 2000;102(7):761–5.
Bernstein AD, et al. The revised NASPE/BPEG generic code for antibradycardia, adaptive-rate, and multisite pacing. North American Society of Pacing and Electrophysiology/British Pacing and Electrophysiology Group. Pacing Clin Electrophysiol. 2002;25(2):260–4.
Miller JN, Drew BJ. Atrial electrograms after cardiac surgery: survey of clinical practice. Am J Crit Care. 2007;16(4):350–6; quiz 357; discussion 358–9.
Carroll KC, et al. Risks associated with removal of ventricular epicardial pacing wires after cardiac surgery. Am J Crit Care. 1998;7(6):444–9.
Luechinger R, et al. In vivo heating of pacemaker leads during magnetic resonance imaging. Eur Heart J. 2005;26(4):376–83; discussion 325–7.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Sen, A. (2020). Left Ventricular Assist Devices and Pacemakers. In: Shiber, J., Weingart, S. (eds) Emergency Department Critical Care. Springer, Cham. https://doi.org/10.1007/978-3-030-28794-8_10
Download citation
DOI: https://doi.org/10.1007/978-3-030-28794-8_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-28792-4
Online ISBN: 978-3-030-28794-8
eBook Packages: MedicineMedicine (R0)